IMNM
Immunome Inc.
$17.30
+$1.23(+7.65%)
56
Overall
55
Value
66
Tech
47
Quality
Market Cap
$1.37B
Volume
1.84M
52W Range
$5.15 - $17.32
Target Price
$24.09
Order:
Income Statement
| Metric | Trend | Chart | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Total Revenue | -- | -- | -- | $14.0M | $9.0M | ||
| Total Revenue | -- | -- | -- | $14.0M | $9.0M | ||
| GROSS PROFIT | |||||||
| Gross Profit | -- | -- | -- | $14.0M | $9.0M | ||
| OPERATING EXPENSES | |||||||
| Operating Expenses | $12.3M | $25.2M | $36.9M | $123.5M | $314.8M | ||
| Research & Development | $7.5M | $14.1M | $23.3M | $23.1M | $129.5M | ||
| Research Expense | $7.5M | $14.1M | $23.3M | $23.1M | $129.5M | ||
| Selling, General & Administrative | $4.8M | $11.1M | $13.6M | $19.7M | $33.0M | ||
| Selling & Marketing Expenses | -- | -- | $622.0K | -- | -- | ||
| General & Administrative Expenses | $4.8M | $11.1M | $13.6M | $19.7M | $33.0M | ||
| Depreciation & Amortization | $800.0K | $800.0K | $400.0K | $500.0K | $1.6M | ||
| Depreciation & Amortization | $800.0K | $800.0K | $400.0K | -- | -- | ||
| OPERATING INCOME | |||||||
| Operating income | $-12.3M | $-25.2M | $-36.9M | $-109.5M | $-305.8M | ||
| EBITDA | $-17.0M | $-24.4M | $-36.3M | $-108.8M | $-303.7M | ||
| NON-OPERATING ITEMS | |||||||
| Interest Expense (Non-Operating) | $38.0K | $10.0K | $-5.0K | $-2.7M | $-12.8M | ||
| Interest Income Operating | $1.0K | -- | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-38.0K | $-10.0K | $5.0K | $2.7M | $12.8M | ||
| Other Income/Expense | $5.5M | $-503.0K | -- | $-80.8M | -- | ||
| Other Special Charges | $-5.5M | $503.0K | -- | -- | -- | ||
| SPECIAL ITEMS | |||||||
| Special Income Charges | -- | -- | $-622.0K | -- | -- | ||
| PRE-TAX INCOME | |||||||
| EBIT | $-17.8M | $-25.2M | $-36.9M | $-109.5M | $-305.8M | ||
| Pre-Tax Income | $-17.8M | $-24.7M | $-36.9M | $-26.0M | $-293.0M | ||
| NET INCOME | |||||||
| Net Income | $-17.8M | $-24.7M | $-36.9M | $-106.8M | $-293.0M | ||
| Net Income (Continuing Operations) | $-17.8M | $-24.7M | $-36.9M | $-106.8M | $-293.0M | ||
| Net Income (Discontinued Operations) | $-17.8M | $-24.7M | $-36.9M | $-106.8M | $-293.0M | ||
| Net Income (Common Stockholders) | $-17.8M | $-24.7M | $-37.5M | $-106.8M | $-293.0M | ||
| TOTALS | |||||||
| Total Expenses | $12.3M | $25.2M | $36.9M | $123.5M | $314.8M | ||
| SHARE & EPS DATA | |||||||
| Average Shares Outstanding | $3.4M | $11.5M | $12.1M | $19.8M | $58.6M | ||
| Average Shares Outstanding (Diluted) | $3.4M | $11.5M | $12.1M | $19.8M | $58.6M | ||
| Shares Outstanding | $10.7M | $12.1M | $12.2M | $87.0M | $87.0M | ||
| Basic EPS | $-5.26 | $-2.14 | $-3.09 | $-5.38 | $-5 | ||
| Basic EPS (Continuing Operations) | $-5.26 | $-2.14 | $-3.09 | $-5.38 | $-5 | ||
| Diluted EPS | $-5.26 | $-2.14 | $-3.09 | $-5.38 | $-5 | ||
| Diluted EPS (Continuing Operations) | -- | $-2.14 | $-3.09 | $-5.38 | $-5 | ||
| OTHER METRICS | |||||||
| Non Recurring Operation Expense | -- | -- | $622.0K | -- | -- | ||
| Other Gand A | $4.8M | $11.1M | $13.6M | $19.7M | $33.0M | ||
| Rent And Landing Fees | $-400.0K | $-500.0K | -- | -- | -- | ||
| Selling Expense | -- | -- | $622.0K | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IMNM | $17.30 | +7.7% | 1.84M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |